Madhukar Pai

Last updated
Madhukar Pai
Born
Vellore, India
Alma mater
Known for Tuberculosis and public health research, equity advocacy
Awards

Madhukar Pai (also known as Madhu Pai) is a Canadian medical doctor, academic, advocate, [1] writer, [2] and university professor. He is the Associate Director of the McGill International Tuberculosis Centre. [3] Pai's work focuses on global health, specifically advocacy for better treatment for tuberculosis [4] [5] with a focus on South Africa and India. [6] [7] Pai is the inaugural Chair of the Department of Global and Public Health in the School of Population and Global Health [8] and holds a Canada Research Chair in Epidemiology and Global Health at McGill University. [9] He is recognised globally, and is a key leader in the decolonising global health movement - recognised for his advocacy on making global health more diverse, inclusive, and equitable. [5] [10]

Contents

Education

Pai completed medical training and his community medicine residency at the Christian Medical College [11] Vellore, India. [6] He received his Ph.D in epidemiology from University of California, Berkeley. [6] He also did a postdoctoral fellowship at the University of California San Francisco. [6]

Committees and editorial boards

Pai serves on the Scientific Advisory Committee of FIND (the global alliance for diagnostics) [6] and is on the World Health Organization's Strategic Advisory Group of Experts on In Vitro Diagnostics and the Access Advisory Committee of TB Alliance. [6] He is the Chair of the Public-Private Mix Working Group of the Stop TB Partnership. [6] Pai is also on the editorial boards of BMJ Global Health, PLoS Medicine, Lancet Infectious Diseases, [6] and is an Editor-in-Chief of PLOS Global Public Health. [12]

Advocacy

Pai is a frequent media commentator on the COVID-19 pandemic in India, [13] [2] [14] and in 2021 drew comparisons of the collective global action taken in response to the COVID19 pandemic versus the relative inaction towards tuberculosis. [15] His 2021 paper in PLOS Medicine addressed power asymmetries in global health. [16]

In 2020 [17] and in 2021 [18] he published papers and contributions about the decolonisation of global health work. His called to address racism and colonialism in Global Health at the AIDS 2022 conference. [19]

In 2021, Pai was critical of the global failure to widely vaccinate people against COVID-19, accused high-income nations of vaccine hoarding, and called for a waiver of intellectual property laws regarding COVID19 vaccines. [20] In 2022 he described the global response to COVID-19 as an "unmitigated disaster". [21]

Awards

Selected publications

Related Research Articles

<span class="mw-page-title-main">Tuberculosis</span> Infectious disease

Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, is a contagious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease that, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. Infection of other organs can cause a wide range of symptoms.

<span class="mw-page-title-main">Kamran Abbasi</span> British physician and sports writer

Kamran Abbasi is a Pakistani-English physician, professor, editor and author.

<span class="mw-page-title-main">Multidrug-resistant tuberculosis</span> Medical condition

Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB medications (drugs): isoniazid and rifampicin. Some forms of TB are also resistant to second-line medications, and are called extensively drug-resistant TB (XDR-TB).

<span class="mw-page-title-main">Bedaquiline</span> Medication used to treat tuberculosis

Bedaquiline, sold under the brand name Sirturo, is a medication used for the treatment of active tuberculosis. Specifically, it is used to treat multi-drug-resistant tuberculosis along with other medications for tuberculosis. It is taken by mouth.

<span class="mw-page-title-main">Tom Frieden</span> American physician

Thomas R. Frieden is an American infectious disease and public health physician. He serves as president and CEO of Resolve to Save Lives, a $225 million, five-year initiative to prevent epidemics and cardiovascular disease.

The Xpert MTB/RIF is a cartridge-based nucleic acid amplification test (NAAT) for rapid tuberculosis diagnosis and rapid antibiotic sensitivity test. It is an automated diagnostic test that can identify Mycobacterium tuberculosis (MTB) DNA and resistance to rifampicin (RIF). It was co-developed by the laboratory of Professor David Alland at the University of Medicine and Dentistry of New Jersey (UMDNJ), Cepheid Inc. and Foundation for Innovative New Diagnostics, with additional financial support from the US National Institutes of Health (NIH).

<span class="mw-page-title-main">Alimuddin Zumla</span> British-Zambian physician

Sir Alimuddin Zumla is a British-Zambian professor of infectious diseases and international health at University College London Medical School, and a Consultant Infectious Diseases physician at UCLHospitals NHS Foundation Trust, London, UK. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, pathogens with epidemic potential and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2024, for the seventh consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences. In 2024, he was elected Member of the prestigious Academy of Europe.

<span class="mw-page-title-main">Muhammad Ali Pate</span> Nigerian physician and politician (born 1968)

Muhammad Ali Pate is a Nigerian physician, politician, and the current Minister of Health and Social Welfare of Nigeria, appointed in 2023. He also serves as a Professor of Public Health Leadership in the Department of Global Health and Population at Harvard University. He is the Director of the Global Financing Facility (GFF) for Women, Children and Adolescents at the World Bank Group.

<span class="mw-page-title-main">Karel Styblo</span>

Karel Styblo was a Czech-Dutch physician. Internationally recognized for his work with tuberculosis (TB), he was a medical advisor to the Royal Netherlands Tuberculosis Association, and was named director of the International Union Against Tuberculosis and Lung Disease (IUATLD) in 1979. He is known as the "father of modern TB epidemiology" and the "father of modern TB control".

<span class="mw-page-title-main">Tuberculosis in India</span> Health issue in India

Tuberculosis in India is a major health problem, causing about 220,000 deaths every year. In 2020, the Indian government made statements to eliminate tuberculosis from the country by 2025 through its National TB Elimination Program. Interventions in this program include major investment in health care, providing supplemental nutrition credit through the Nikshay Poshan Yojana, organizing a national epidemiological survey for tuberculosis, and organizing a national campaign to tie together the Indian government and private health infrastructure for the goal of eliminating the disease.

The Chanchlani Global Health Research Award is a Canadian health sciences award that recognizes a world leading scholar in the area of Global Health. Each year a discipline within Global Health is chosen by the internal review committee at McMaster University. The review committee then selects the leading researcher based on interview and impact in the field. The award recipient receives a monetary prize of $5,000 and opportunity to present their research findings to researchers and students.

<span class="mw-page-title-main">Soumya Swaminathan</span> Indian and WHO Deputy Director general

Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. Previously, from October 2017 to March 2019, she was the deputy director general of programmes (DDP) at the World Health Organization.

<span class="mw-page-title-main">Lalita Ramakrishnan</span> Indian-American microbiologist

Lalita Ramakrishnan is an Indian-born American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis. As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician. Her research is conducted at the MRC Laboratory of Molecular Biology, where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis. Her work has appeared in a number of journals, including Science, Nature, and Cell. In 2018 and 2019 Ramakrishnan coauthored two influential papers in the British Medical Journal (BMJ) arguing that the widely accepted estimates of the prevalence of latent tuberculosis—estimates used as a basis for allocation of research funds—are far too high. She is married to Mark Troll, a physical chemist.

<span class="mw-page-title-main">Jocalyn Clark</span>

Jocalyn Clark is a Canadian Public Health Scientist and the International Editor of The BMJ, with responsibility for strategy and internationalising the journal's content, contributors and coverage. From 2016 to 2022, Jocalyn was an Executive Editor at The Lancet, where she led the Commentary section, coordinated peer review, and edited and delivered collections of articles and Commissions on topics such as maternal and child health, oral health, migration, end of life care and gender equity. She led the Lancet's project to advance women in science, medicine, and global health, #LancetWomen. She is also an adjunct professor of Medicine at the University of Toronto and an Honorary Associate Professor at the Institute for Global Health at UCL.

Roopa Dhatt is an Indian American physician, an Assistant Professor and Internal Medicine Hospitalist at Georgetown University Medical Center, and at a community hospital, Washington, DC. In 2015 she co-founded Women in Global Health, which aims to reduce gender disparity among global health leaders, and subsequently became the organisation's Executive Director.

<span class="mw-page-title-main">Catharina Boehme</span> Medical scientist

Catharina Boehme is the Assistant Director-General for External Relations and Governance of the World Health Organization. She previously served as WHO Chef de Cabinet, and is known for her work in developing diagnostic tests for diseases such as tuberculosis and for advocating for increased testing for the COVID-19 disease.

Elimination of tuberculosis is the effort to reduce the number of tuberculosis (TB) cases to less than one per 1 million population, contrasted with the effort to completely eradicate infection in humans worldwide. The goal of tuberculosis elimination is hampered by the lack of rapid testing, short and effective treatment courses, and completely effective vaccine. The WHO as well as the Stop TB Partnership aim for the full elimination of TB by 2050—requiring a 1000-fold reduction in tuberculosis incidence. As of 2017, tuberculosis has not been eliminated from any country.

Rachel Kiddell-Monroe LL.M is a Montreal-based academic, activist, and lawyer. She is the General Director of See Change Initiative and faculty at McGill University where she teaches about humanitarian aid.

<span class="mw-page-title-main">Nina Schwalbe</span> American public health researcher

Nina Schwalbe is an American public health researcher who is the founder of Spark Street Advisors, a public health think tank based in New York City. Schwalbe specializes in vaccines. She has previously worked at Gavi, UNICEF and USAID.

Dr. Haileyesus (Haile) Getahun is an Ethiopian global health leader, researcher, and advocate. He is currently the chief executive officer of HeDPAC, an organization dedicated to strengthening south-to-south partnerships in health development and founder of CeHDI. Before HEDPAC's role, he served at the WHO headquarters in Geneva from 2003 to 2024, where he led numerous global health initiatives.

References

  1. ↑ Dustin, Graham (2018-09-24). "Backstory Podcast: Dr. Madhukar Pai discusses the UN High Level Meeting to End TB". On Medicine. Retrieved 2021-11-13.
  2. 1 2 "Opinion | India's covid-19 crisis is a dire warning for all countries". Washington Post. ISSN   0190-8286 . Retrieved 2021-11-13.
  3. ↑ https://www.forbes.com/sites/madhukarpai/
  4. ↑ "Pai M[Author] - Search Results - PubMed". PubMed. Retrieved 2021-11-13.
  5. 1 2 "Madhukar Pai: TB and global health expert". BMJ (Clinical research ed.). 360: k1173. 2018-03-21. doi:10.1136/bmj.k1173. ISSN   1756-1833. PMC   5861521 . PMID   29563099.
  6. 1 2 3 4 5 6 7 8 9 10 11 12 "Madhukar Pai". McGill University.
  7. ↑ "Madhukar Pai, MD, PhD - Research Institute of the McGill University Health Centre - RI-MUHC". Research Institute of the McGill University Health Centre. Retrieved 2021-11-13.
  8. ↑ "Alumnus Madhukar Pai named chair of Department of Global and Public Health at McGill University". Berkeley Public Health. 2023-09-28. Retrieved 2024-02-28.
  9. ↑ "The Chair". Department of Global and Public Health. Retrieved 2024-02-28.
  10. ↑ "Global health researcher Madhukar Pai believes scientific innovations must reach everyone". December 4, 2024.{{cite web}}: |first= missing |last= (help)CS1 maint: url-status (link)
  11. ↑ Pai, Madhu (March 2021). "Madhu Pai CV" (PDF).
  12. ↑ "PLOS Global Public Health: A Peer-Reviewed Open-Access Journal". journals.plos.org. Retrieved 2021-11-15.
  13. ↑ The National (2021). "Canadian doctor weighs in on COVID-19 crisis in India". CBC.
  14. ↑ "Analysis | As India sets a record for covid-19 deaths, variant worries grow globally". Washington Post. ISSN   0190-8286 . Retrieved 2021-11-13.
  15. ↑ Furin, Jennifer; Pai, Madhukar (2021-03-22). "We went all-out to tackle Covid-19 – TB needs the same approach". The Telegraph. ISSN   0307-1235 . Retrieved 2021-11-13.
  16. ↑ Abimbola, Seye; Asthana, Sumegha; Montenegro, Cristian; Guinto, Renzo R.; Jumbam, Desmond Tanko; Louskieter, Lance; Kabubei, Kenneth Munge; Munshi, Shehnaz; Muraya, Kui; Okumu, Fredros; Saha, Senjuti (2021-04-22). "Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic". PLOS Medicine. 18 (4): e1003604. doi: 10.1371/journal.pmed.1003604 . ISSN   1549-1676. PMC   8101997 . PMID   33886540.
  17. ↑ Abimbola, Seye; Pai, Madhukar (2020-11-21). "Will global health survive its decolonisation?". The Lancet. 396 (10263): 1627–1628. doi:10.1016/S0140-6736(20)32417-X. ISSN   0140-6736. PMID   33220735. S2CID   227064067.
  18. ↑ Pai, Madhukar. "Decolonizing Global Health: A Moment To Reflect On A Movement". Forbes. Retrieved 2021-11-15.
  19. ↑ TBPPM Learning Network (2022-08-09). A call to address racism and colonialism in Global Health | Prof. Madhukar Pai at AIDS 2022 . Retrieved 2025-01-28– via YouTube.
  20. ↑ Valentine, Ashish (2021-12-09). "Fix the global vaccine rollout or face even worse COVID variants, experts warn". NPR. Retrieved 2021-12-14.
  21. ↑ "Infectious disease expert calls global COVID-19 response an 'unmitigated disaster'". Coronavirus. 2022-01-25. Retrieved 2022-03-03.
  22. ↑ "Cell Press - Search Results: Cell Press". www.cell.com. Archived from the original on 2024-11-26. Retrieved 2025-01-28.
  23. ↑ "Dr Madhukar Pai Honored with Dr PRJ Gangadharam Endowment Award". www.mgims.ac.in. Retrieved 2025-01-28.
  24. ↑ "Dr. Madhukar Pai and Dr. Nitika Pai co-laureates of the 2012 Chanchla…". archive.md. 2013-06-30. Archived from the original on 2013-06-30. Retrieved 2021-11-13.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.